Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

for
Fallopian Tube Cancer, Ovarian Cancer,
Location: Atlanta GA
Sponsor: Southeastern Gynecologic Oncology

Sex: Female

Age: 0+

Code: NCT00897039

Recruiting

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

for
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 2 - 18

Code: NCT00036712

Phase 2, Recruiting

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer,
Location: Los Gatos CA
Sponsor: Bay Area Gynecology Oncology

Sex: All

Age: 18 - 70+

Code: NCT02349958

Phase 2, Recruiting

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: Female

Age: 0+

Code: NCT04469764

Phase 2, Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

for
Non-Small Cell Lung Cancer,
Location: Montreal, Fairfax VA, Durham NC, Toronto,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

for
Malignant Ovarian Epithelial Tumor,
Location: Detroit MI, Flint MI
Sponsor: Ira Winer

Sex: Female

Age: 18+

Code: NCT04055649

Phase 2, Recruiting

A Study Evaluating MM-310 in Patients With Solid Tumors

for
Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma,
Location: Durham NC, Buffalo NY, Rochester MN, Scottsdale AZ,
Sponsor: Merrimack Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03076372

Phase 1, Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase 1, Phase 2, Recruiting
Active & Responsive

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

for
Ovarian Cancer
Location: Providence RI, Morristown NJ, Rochester NY, Miami FL,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 50 - 70+

Code: NCT00539162

Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

for
Colorectal Cancer, Epithelial Ovarian Cancer, Gastric Cancer,
Location: Dallas TX
Sponsor: Blue Earth Diagnostics

Sex: All

Age: 18 - 70+

Code: NCT07432633

Phase 1, Phase 2, Recruiting

Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Knoxville TN
Sponsor: University of Tennessee Graduate School of Medicine

Sex: Female

Age: 18+

Code: NCT07764133

Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

for
Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma,
Location: East Brunswick NJ, Philadelphia PA, York PA,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 18+

Code: NCT05059444

Recruiting

Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

for
Ovarian Clear Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06065462

Phase 1, Phase 2, Recruiting

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

for
Cervical Cancer, Endometrial Cancer, Ovarian Epithelial Cancer
Location: Maywood IL
Sponsor: Bital Savir-Baruch

Sex: Female

Age: 18+

Code: NCT03349463

Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

for
Endometrial Cancer, Endometrioid Adenocarcinoma,
Location: Hartford CT, Commack NY, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT04291612

Recruiting

Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma

for
Epithelial Ovarian Carcinoma
Location: Newport Beach CA
Sponsor: Gynecologic Oncology Associates

Sex: Female

Age: 18+

Code: NCT02437812

Phase 2, Recruiting

Familial Investigations of Childhood Cancer Predisposition

for
Acute Leukemia, Adenomatous Polyposis, Adrenocortical Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT03050268

Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

for
Ovarian Cancer, Epithelial, Gastric Cancer,
Location: Charlottesville VA, Chapel Hill NC, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05107674

Phase 1, Recruiting

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

for
Metastatic Malignant Solid Neoplasm,
Location: Boston MA, Deerfield Beach FL, Coral Gables FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04585958

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial